APA (7th ed.) Citation

Martín, M., García-Puche, J., Casado, A., Talavera, M., Menéndez, M., Alba, E., . . . Díaz-Rubio, E. (2003). High-dose DICEP chemotherapy versus observation in metastatic breast cancer patients with monotopic disease responding to induction chemotherapy with paclitaxel plus epirubicin. Final results of a phase III GEICAM trial. Clinical & translational oncology: official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 5(3), 148. https://doi.org/10.1007/BF02712849

Chicago Style (17th ed.) Citation

Martín, Miguel, et al. "High-dose DICEP Chemotherapy Versus Observation in Metastatic Breast Cancer Patients with Monotopic Disease Responding to Induction Chemotherapy with Paclitaxel Plus Epirubicin. Final Results of a Phase III GEICAM Trial." Clinical & Translational Oncology: Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 5, no. 3 (2003): 148. https://doi.org/10.1007/BF02712849.

MLA (9th ed.) Citation

Martín, Miguel, et al. "High-dose DICEP Chemotherapy Versus Observation in Metastatic Breast Cancer Patients with Monotopic Disease Responding to Induction Chemotherapy with Paclitaxel Plus Epirubicin. Final Results of a Phase III GEICAM Trial." Clinical & Translational Oncology: Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, vol. 5, no. 3, 2003, p. 148, https://doi.org/10.1007/BF02712849.